Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cerebral Microangiopathy”

502 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 502 results

Post-approval studies (Phase 4)UnknownNCT05583266
What this trial is testing

Efficacy of Pentoxifylline on Cerebrovascular Function in Patients With Cerebral Small Vessel Disease(PERFORM)

Who this might be right for
Cerebral Small Vessel Diseases
Beijing Tiantan Hospital 80
Not applicableLooking for participantsNCT06933212
What this trial is testing

Effect of the Mediterranean Diet in Patients Affected by CADASIL and Cerebral Amyloid Angiopathy.

Who this might be right for
Cerebral Amyloid AngiopathyCAA - Cerebral Amyloid Angiopathy
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 86
Not applicableStudy completedNCT03432871
What this trial is testing

Nicotinamide Riboside and Mitochondrial Biogenesis

Who this might be right for
Mitochondrial DiseasesMitochondrial MyopathiesProgressive External Ophthalmoplegia+4 more
Cambridge University Hospitals NHS Foundation Trust 13
Not applicableStudy completedNCT00728364
What this trial is testing

Anderson-Fabry Disease in Chronic Kidney Disease Patients Not on Renal Replacement Therapy

Who this might be right for
Focus of Study: Prevalence of Fabry Disease in CKD Population
Klinikum Wels-Grieskirchen 4,353
Not applicableLooking for participantsNCT05567744
What this trial is testing

Registry for CADASIL

Who this might be right for
Cerebral Autosomal Dominant Ateriopathy With Subcortical Infarcts and Leukoencephalopathy
University of Wisconsin, Madison 2,500
Testing effectiveness (Phase 2)Study completedNCT03855332
What this trial is testing

Oxford Haemodynamic Adaptation to Reduce Pulsatility Trial

Who this might be right for
Small Vessel Cerebrovascular Disease
University of Oxford 75
Large-scale testing (Phase 3)Study completedNCT03566017
What this trial is testing

Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease

Who this might be right for
Fabry Disease
Chiesi Farmaceutici S.p.A. 97
Not applicableUnknownNCT05679076
What this trial is testing

A Qualitative Study on the Pain and Quality of Life of Patients With Fabry Disease

Who this might be right for
Fabry Disease
Yonsei University 10
Not applicableStudy completedNCT00001774
What this trial is testing

Vasodilation in Patients With Fabry's Disease

Who this might be right for
Cerebrovascular AccidentFabry DiseaseHealthy
National Institute of Neurological Disorders and Stroke (NINDS) 48
Not applicableLooking for participantsNCT06813443
What this trial is testing

Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation

Who this might be right for
CardiomyopathiesAmyloidosis CardiacFabry Disease+14 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 700
Not applicableStudy completedNCT01374997
What this trial is testing

Detection of Fabry Disease in Chronic Renal Failure Patients in Area Provence - Alpes - Côte d'Azur

Who this might be right for
Fabry Disease
Centre Hospitalier Universitaire de Nice 6
Post-approval studies (Phase 4)Study completedNCT00163150
What this trial is testing

Vasomotor Reactivity In Cerebral Small Vessel Disease And New Approach To Treat Lacunar Stroke

Who this might be right for
Cerebrovascular AccidentHypercholesterolemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 128
Not applicableUnknownNCT05052788
What this trial is testing

OCT Angio in Cerebral Small Vessel Disease

Who this might be right for
Cerebral Small Vessel Disease and OCT Angio
Ain Shams University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06402123
What this trial is testing

A Phase 2b Study of Zagociguat in Patients With MELAS

Who this might be right for
Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)
Tisento Therapeutics 43
Early research (Phase 1)Study completedNCT00405860
What this trial is testing

CellCept in p-ANCA Vasculitis

Who this might be right for
MPO-ANCA VasculitisMicroscopic Polyangiitis
Mayo Clinic 18
Large-scale testing (Phase 3)UnknownNCT00349674
What this trial is testing

WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated Vasculitides

Who this might be right for
Systemic Wegener's Granulomatosis
Hospices Civils de Lyon 126
Not applicableLooking for participantsNCT06474507
What this trial is testing

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Ischemic Cerebral Vascular Disease (CBSinICVD)

Who this might be right for
Ischemic Cerebrovascular DiseaseAcute Ischemic StrokeCerebral Small Vessel Diseases
Tongji Hospital 230
Not applicableLooking for participantsNCT06607471
What this trial is testing

Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.

Who this might be right for
Non-ischemic CardiomyopathyDilated Cardiomyopathy (DCM)Hypertrophic Cardiomyopathy (HCM)+12 more
Scientific Institute San Raffaele 15,000
Not applicableStudy completedNCT00315393
What this trial is testing

Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis

Who this might be right for
Granulomatosis With PolyangiitisMicroscopic PolyangiitisWegener's
University of Pennsylvania 1,046
Not applicableStudy completedNCT01268241
What this trial is testing

The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry Disease

Who this might be right for
Fabry DiseaseFabry´s DiseaseAnderson-Fabry Disease
CENTOGENE GmbH Rostock 200
Load More Results